Triple therapy prolongs progression-free survival in Multiple Myeloma
1. Adding the proteasome inhibitor Ixazomib to lenalidomide and dexamethasone significantly increased progression-free survival compared to lenalidomide and dexamethasone ...
1. Adding the proteasome inhibitor Ixazomib to lenalidomide and dexamethasone significantly increased progression-free survival compared to lenalidomide and dexamethasone ...
1. A sustained decrease of up to 12 months in serum IgA measurements was demonstrated after administration of CTL019 transfusion ...
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects, ...
1. Adding elotuzumab to the conventional lenalidomide and dezamethasone was associated with a 30% reduction in the risk of disease ...
Originally published by Harvard Health. What Is It? Multiple myeloma is cancer of the bone marrow caused by the uncontrolled ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Use ...
1. Progression-free survival was improved by about 3 months with continuous lenalidomide-dexamethasone compared to standard melphalan-prednisone-thalidomide. 2. Overall survival was ...
Image: PD RANKL protein structure 1. Continued monoclonal protein response to autologous stem cell transplantation (ASCT) is associated with improved ...
In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week. ...
Image: CC/Osaro 1. Treatment with lenalidomide and dexamethasone significantly delayed disease progression in patients with smoldering multiple myeloma who were ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.